-+ 0.00%
-+ 0.00%
-+ 0.00%

AKEBIA THERAPEUTICS INC - AKB-097 TO ENTER PHASE 2 BASKET TRIAL IN RARE KIDNEY DISEASES IN SECOND HALF OF 2026

Reuters·04/13/2026 12:00:03

Please log in to view news